Browse by Section 100 Item List

Highly Specialised Drugs Program (Private Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through private hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in private hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Private hospital prescriptions for Highly Specialised Drugs can be dispensed by an approved private hospital dispensary or by a community pharmacy. A patient will be required to pay a contribution for each supply of a highly specialised drug at the same rate as the PBS.

The remuneration rates for Highly Specialised Drugs prescribed through private hospitals comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:

  • 10% for drugs with an ex-manufacturer price of less than $40
  • $4 for drugs with an ex-manufacturer price of between $40 and $100
  • 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
  • $40 for drugs with an ex-manufacturer price of greater than $1000.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
  • SO
    Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
    Supply Only
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 10182X ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 0
MP 10192K ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 4
MP 10194M ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 5
MP 12864C ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 0
MP 12896R ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 8 8 0
MP 12899X ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 6 6 5
MP 14804E EDARAVONEedaravone 30 mg/20 mL injection, 10 x 20 mL ampoules 2.8 28 0
MP 14900F EFLORNITHINEeflornithine 192 mg tablet, 100 3 300 2
MP 14910R EFLORNITHINEeflornithine 192 mg tablet, 100 3 300 2
MP 13266F ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 1 1 5
MP 14280N ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 1 1 5
MP 14279M ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 1 1 5
MP 12938Y ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 1 1 5
MP 14115X ELTROMBOPAGeltrombopag 25 mg tablet, 28 3 84 3
MP 14119D ELTROMBOPAGeltrombopag 25 mg tablet, 28 3 84 5
MP 14136B ELTROMBOPAGeltrombopag 25 mg tablet, 28 3 84 5
MP 5827Q ELTROMBOPAGeltrombopag 25 mg tablet, 28 1 28 5
MP 14107L ELTROMBOPAGeltrombopag 50 mg tablet, 28 3 84 3
MP 14127M ELTROMBOPAGeltrombopag 50 mg tablet, 28 3 84 5
MP 14143J ELTROMBOPAGeltrombopag 50 mg tablet, 28 3 84 5
MP 5828R ELTROMBOPAGeltrombopag 50 mg tablet, 28 1 28 5
MPNP 6206P EPOETIN ALFAepoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes 2 12 5
MPNP 6339P EPOETIN ALFAepoetin alfa 40 000 units/mL injection, 1 mL syringe 2 2 5
MPNP 6302Q EPOETIN ALFAepoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MPNP 6303R EPOETIN ALFAepoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MPNP 6305W EPOETIN ALFAepoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes 2 12 5
MPNP 6251B EPOETIN ALFAepoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MPNP 6207Q EPOETIN ALFAepoetin alfa 10 000 units/mL injection, 6 x 1 mL syringes 2 12 5
MPNP 6204M EPOETIN ALFAepoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MPNP 6434P EPOETIN ALFAepoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MPNP 6205N EPOETIN ALFAepoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MPNP 6485H EPOETIN BETAepoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MPNP 6480C EPOETIN BETAepoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MPNP 6481D EPOETIN BETAepoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MPNP 6482E EPOETIN BETAepoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MPNP 6483F EPOETIN BETAepoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MPNP 6484G EPOETIN BETAepoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MPNP 9588P EPOETIN LAMBDAepoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MPNP 9590R EPOETIN LAMBDAepoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MPNP 9593X EPOETIN LAMBDAepoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes 2 12 5
MPNP 9685R EPOETIN LAMBDAepoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MPNP 9595B EPOETIN LAMBDAepoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes 2 12 5
MPNP 9686T EPOETIN LAMBDAepoetin lambda 2000 units/mL injection, 6 x 1 mL syringes 2 12 5
MPNP 9687W EPOETIN LAMBDAepoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MPNP 9688X EPOETIN LAMBDAepoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes 2 12 5
MP 10129D EPOPROSTENOLepoprostenol 1.5 mg injection, 1 vial 30 30 5
MP 10111E EPOPROSTENOLepoprostenol 500 microgram injection, 1 vial 30 30 5
MP 14787G ESKETAMINEesketamine 28 mg/2 actuations nasal spray, 2 actuations 8 8 0
MP 14811M ESKETAMINEesketamine 28 mg/2 actuations nasal spray, 2 actuations 4 4 5
MP 14814Q ESKETAMINEesketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations 4 8 5
MP 14831N ESKETAMINEesketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations 8 16 0
MP 14798W ESKETAMINEesketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations 4 12 5
MP 14823E ESKETAMINEesketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations 8 24 0
MP 13326J ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices 1 1 5
MP 9641K ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices 1 1 0
MP 13295R ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack 2 2 5
MP 6367D ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack 1 1 0
MP 13332Q ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes 1 1 5
MP 9615C ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes 1 1 0
MP 6459Y EVEROLIMUSeverolimus 250 microgram tablet, 60 2 120 5
MP 6460B EVEROLIMUSeverolimus 500 microgram tablet, 60 2 120 5
MP 6461C EVEROLIMUSeverolimus 750 microgram tablet, 60 4 240 5
MP 9582H EVEROLIMUSeverolimus 1 mg tablet, 60 4 240 5